SNR1 is an essential subunit in a subset of drosophila brm complexes, targeting specific functions during development  by Zraly, Claudia B et al.
SNR1 is an essential subunit in a subset of Drosophila brm complexes,
targeting specific functions during development
Claudia B. Zraly,a Daniel R. Marenda,a Runjhun Nanchal,a Giacomo Cavalli,b
Christian Muchardt,c and Andrew K. Dingwalla,*
a Department of Biology, Syracuse University, Syracuse, NY 13244-1270, USA
b Institut de Ge´ne´tique Humaine, CNRS, Montpellier 34396, France
c Expression Ge´ne´tique et Maladies, URA 1644 du CNRS, De´partement Biologie du De´veloppement, Institut Pasteur, Paris, France
Received for publication 27 September 2002, accepted 27 September 2002
Abstract
The snr1 gene of Drosophila melanogaster encodes a conserved component of the multiprotein Brahma (Brm) complex, a counterpart
to the SWI/SNF complexes that participate in ATP-dependent chromatin remodeling. Loss-of-function and null mutations in the snr1 gene
reveal its essential role in Drosophila development. We identified new mutant alleles and ectopically expressed deleted forms to dissect the
specific functions of SNR1. Somatic and germ cell clone analyses confirmed its requirement in a continuous and widespread fashion for
proper cell fate determination and oogenesis. Expression of SNR1 transgenes revealed unexpected roles in wing patterning, abdomen
development, oogenesis, and sustained adult viability. A widespread distribution of SNR1 and BRM on the salivary gland polytene
chromosomes showed that the Brm complex associated with many genes, but not always at transcribed loci, consistent with genetic data
suggesting roles in both gene activation and repression. Despite essential Brm complex functions in leg development, genetic and protein
localization studies revealed that snr1 was not required or expressed in all tissues dependent on Brm complex activities. Thus, SNR1 is
essential for some, but not all Brm functions, and it likely serves as an optional subunit, directing Brm complex activity to specific gene
loci or cellular processes.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Throughout metazoan development, groups of genes are
activated and repressed in distinct temporally and spatially
restricted patterns. Cell determination requires that specific
genes be targeted for induced expression, or silenced, in
response to growth signals. The competence of a gene to be
expressed is determined by inductive events during devel-
opment, and once established, this competence is epigeneti-
cally heritable through subsequent cell divisions, in some
instances maintained through the maternal germline (Cav-
alli and Paro, 1998, 1999). This type of cellular memory is
somehow “imprinted” through affects on chromatin archi-
tecture. In all eukaryotic cells, chromatin structure serves to
control the accessibility of transcription regulatory proteins
to specific sites and imposes a default state in which genetic
information is repressed by higher order structures. The
SWI/SNF complexes, identified in yeast, flies (Brm com-
plex), and mammals (hBrm and BRG1 complexes), are
large (2 MDa) multisubunit assemblies (8–11 proteins)
that alter or remodel the structure of chromatin in an energy-
dependent fashion.
While the biochemical properties of the purified yeast
and human SWI/SNF complexes have been studied in great
detail (Kingston et al., 1996; Kingston and Narlikar, 1999),
the in vivo functions are less well understood. The SWI2/
SNF2 ATPase subunit alone is partially sufficient for nu-
cleosome disruption in vitro, and only 4 subunits of the
mammalian complex, BRG1, INI1/hSNF5, BAF155, and
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BAF170, are required for full in vitro ATP-dependent chro-
matin remodeling activity (Phelan et al., 1999). Therefore,
the additional 5–11 subunits may modulate complex func-
tions or provide target specificity. The SWI/SNF complex
can be recruited to specific sites through direct interactions
with gene-specific activators (Peterson and Workman,
2000) with several complex subunits functioning coordi-
nately to facilitate these associations (Neely et al., 1999,
2002); however, little is known regarding the specific pro-
tein interactions that promote such recruitment.
Components of the Drosophila Brm complex were ini-
tially identified through genetic screens for regulators of
homeotic (HOM) gene expression (Tamkun, 1995; Kenni-
son and Tamkun, 1988) affecting leg development. The
brm, mor, and osa genes serve as activators to counteract
the effects of the Polycomb group (Pc-G) of genes that
maintain the repressed state of HOM gene expression. Ho-
mology between BRM and yeast SWI2/SNF2 within the
ATPase domain and the discovery of snr1, a fly homolog of
SNF5, strongly suggested that a counterpart to the SWI/SNF
complex was involved in maintaining active HOM gene
expression in flies (Dingwall et al., 1995; Tamkun et al.,
1992). The Brm complex purified from embryos is com-
prised of 8–10 stably associated subunits, including BRM,
MOR, SNR1, and OSA (Collins et al., 1999; Crosby et al.,
1999; Dingwall et al., 1995; Papoulas et al., 1998). While
brm, mor, and osa are dosage-limiting for most Brm com-
plex functions, no other subunit was identified in any ge-
netic screen. One hypothesis is that the additional Brm
complex subunits, including snr1, are important for re-
stricted or limited functions, perhaps regulating locus- or
process-specific complex activities, and thus might not be
continuously required in stoichiometric quantities in all tis-
sues. An attractive alternative hypothesis is that other than
a “catalytic core,” which includes the BRM ATPase, some
components may be optional and thus either transiently
associated or not present in all tissues where Brm complex
functions have been identified.
The snr1 gene (SNF5-Related-1) is highly conserved
with counterparts in both mammals (INI1/SMARCB1/
hSNF5) and yeast (SNF5). While mutations in SNF5 are not
lethal, the snr1 and INI1 genes are essential for normal
development (Dingwall et al., 1995; Klochendler-Yeivin et
al., 2000). Further, biallelic disruption of INI1, but no other
mammalian hBrm or Brg1 complex gene, is strongly
(90%) associated with aggressive rhabdoid (MRT) tumors
(Sevenet et al., 1999; Versteege et al., 1998), suggesting that
INI1 serves as a tumor suppressor. Although several studies
have suggested that SNR1 and INI1 are stoichiometric core
components in their respective SWI/SNF-type complexes
(Papoulas et al., 1998; Phelan et al., 1999; Wang et al.,
1996), there is mounting genetic evidence suggesting that
snr1 and INI1 may not be required for all complex func-
tions, challenging definitions of a “core” subunit. For ex-
ample, although mutations in snr1 exhibit genetic interac-
tions with brm, osa, and trx in the dorsal prothorax, eyes,
and abdomen (Collins et al., 1999; Dingwall et al., 1995), it
does not appear to be dosage-limiting for Brm complex
functions in the leg (Bajusz et al., 2001; Dingwall et al.,
1995; Kennison and Tamkun, 1988), a test that is often used
to define members of the trx-G of gene activators (Kenni-
son, 1995). Thus, the lack of snr1 mutant dosage-sensitivity
was surprising, suggesting that SNR (INI1) is only required
for a limited set of Brm complex functions or that it has
activities independent of the complex. To distinguish
among these and other possibilities, we employed genetic
screens to identify new snr1 mutant alleles, examined so-
matic and germline null mutant clones, and ectopically
expressed SNR1 deletions. Our results demonstrate that
snr1 is essential and its function is important for oogenesis
and proper development of a restricted set of tissues, in-
cluding the peripheral nervous system, abdomen, and wings
and an unanticipated role in sustaining adult viability; how-
ever, snr1 is not required for proper leg development. In
support of our genetic studies, snr1 mRNA is present in
adult males, and while SNR1 is broadly expressed, it is not
detectably present in a subset of tissues where BRM is
found, including the leg discs (Elfring et al., 1998). These
genetic and expression data are consistent with the hypoth-
esis that SNR1 is an optional component required for Brm
complex functions in restricted tissues; in particular, by
several criteria, SNR1 does not appear to be important for
critical Brm complex functions in regulating genes involved
in leg development. Moreover, we show that SNR1 and
BRM are present together at many locations on the salivary
gland polytene chromosomes often overlapping with RNA
Polymerase II, suggesting a wide array of potential in vivo
targets for gene regulation. The Brm complex and PolII are
also found at a limited number of nonoverlapping chromo-
somal sites, raising the possibility that the Brm complex
might be involved in regulating other cellular processes
through effects on chromatin structure.
Materials and methods
Fly strains and media
Flies were raised on standard cornmeal/dextrose medium
at 25°C unless otherwise noted. The mutations and chro-
mosome aberrations used are shown in Fig. 1 or described
in FlyBase (http://flybase.bio.indiana.edu). Mutant alleles of
snr1 were induced by ethane methylsulfonate (EMS) mu-
tagenesis (Zraly et al., 2002) or P-element excision (Ding-
wall et al., 1995). Accessory recessive mutations were re-
moved by recombination with a multiply marked third
chromosome (stI, KiI, pP) and verified by transgene rescue.
Generation of rescue and snr1 deletion transgene lines
A genomic phage library (Tamkun et al., 1992) was
screened by using a snr1 cDNA. An 8.9-kilobase (kb)
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EcoRI restriction fragment containing 5.7 kb of genomic
DNA 5 and 1 kb 3 to snr1 was cloned into a P transfor-
mation vector (Pirrotta, 1988). Transgenic lines (w, P[w,
gr.snr1]) were established and insertions mapped to spe-
cific chromosomes. An inducible full-length snr1 cDNA
was generated by using a 1.4-kb SspI–NotI fragment cloned
into pCaSpeR-hs and transgene lines established. A second
(II) chromosome transgene was used for snr1 cDNA rescue
analyses (w; P[w, hs.snr1]), with expression verified by
Western blot analysis of embryo extracts following heat
shock (data not shown).
Molecular analysis of new snr1 alleles
Genomic DNA was prepared from snr1 mutant first
instar larvae (Garazzo and Christenson, 1994; Gloor and
Engels, 1992). The snr1 gene was amplified with ExTaq
polymerase (Takara) by using gene-specific primers, and
products were gel-purified and fully sequenced (BioRe-
source Center, Cornell University).
Protein extracts were prepared from control and snr1
mutant pupae (Dingwall et al., 1995; Zraly et al., 2002),
fractionated by 10% SDS–PAGE, then probed with anti-
SNR1 antibodies. Goat anti-rabbit HRP-conjugated second-
ary antibody (Jackson ImmunoResearch) and enhanced
chemiluminescence (Pierce) were used for detection.
Mosaic analyses
The FLP/FRT system was used to induce somatic and
germline clones of a strong loss-of-function snr1R3 muta-
tion, as described (Golic and Lindquist, 1989; Xu and Ru-
bin, 1993). To generate a recombinant chromosome, w1118;
P[ry, hs-neo, FRT]82B flies were crossed with w1118;
P[w]82F. G418-resistant (neor) recombinants (w1118;
P[ry, hs-neo, FRT]82B, P[w]82F) were selected and
crossed to w1118; snr1R3/TM6B. Recombinants (w1118;
P[ry, hs-neo, FRT]82B, snr1R3) were recovered at low
frequency (1  104) and verified by PCR using neo-
specific primers, complementation tests, and transgene res-
cue.
Somatic clones were generated by using hs-FLP recom-
binase carried on the first chromosome (y, w, P[hs-FLP]).
Clones were induced in flies of the genotype (y, w, P[hs-
FLP]; P[ry, hs-neo, FRT]82B, snr1R3/P[ry, hs-neo,
FRT]82B, P[ry, y]96E, Sb) by exposing larvae to a 37°C
heat-shock for 1 h, followed by recovery and incubation at
25°C until eclosion. Clones (snr1 /) were scored based
on the appearance of y, non-Sb bristles. As controls, clones
were produced in parallel from chromosomes that carried
the FRT alone and from non-heat-shock animals. Abnormal
bristle phenotypes were scored as the appearance of short-
ened, bent, fused, twinned, or missing bristles based on the
Fig. 1. Molecular analysis of snr1 mutations. (Top) SNR1 protein structure, conservation with INI1 (% identity), and location of mutations. Conserved regions
among SNF5-family members include two Repeat domains that mediate critical protein interactions and a coiled coil. (Middle) snr1 mutations are nulls by
Western blot. Reduced protein levels and no truncated forms are observed in extracts prepared from snr1 mutant strains. (Bottom) Genomic region used for
rescue transgene constructs and location of snr1.
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criteria used previously to score brm clones (Elfring et al.,
1998).
The production of germline clones followed standard
procedures (Chou and Perrimon, 1996). Larvae were heat-
shocked at 37°C for 60 min during both the first and third
instar larval periods. Virgin females of the appropriate ge-
notype (y, w, P[hs-FLP]; P[ry, hs-neo, FRT]82B, snr1R3/
P[ry, hs-neo, FRT]82B, P[wmC, ovoD1-18]C13X3a) were
crossed to w males and allowed to lay eggs for 14 days.
Control crosses were tested in parallel by using appropri-
ately marked females (y, w, P[hs-FLP]; P[ry, hs-neo,
FRT]82B, P[y], Sb/P[ry, hs-neo, FRT]82B, P[wmC,
ovoD1-18]C13X3a).
Ectopic expression of snr1 transgenes and rescue
analyses
Females (w1118, P[w, gr.snr1];TM3/TM6B or w1118;
P[w, gr.snr1];TM3/TM6B) were crossed to snr1 mutant
males (w1118, snr1*/TM6B). Male progeny carrying both the
transgene and the snr1 allele were then crossed to either the
same or another mutant allele to assess rescue frequency.
The full-length snr1 cDNA under the control of the HSP70
heat-shock promoter was induced at 37°C for 30 min every
12 h during development (w1118;P[w, hsp70-snr1];snr1*/
TM6B). Rescue ability was measured by comparing with
non-heat-shocked flies of the same genotypes.
Deletions of the snr1 cDNA were constructed and cloned
into pUAST (Brand et al., 1994). UAS:snr1-1 (aa 1–370)
contains a SspI–NotI fragment that includes the full-length
snr1cDNA (including both 5 and 3 UTRs), UAS:snr1-2
(aa 1–261; also known as snr1-cdel.3; Brumby et al., 2002),
UAS:snr1-3 (aa 1–155), and UAS:snr1-4 (aa 1–44). All
constructs retain the snr1 5 UTR (see Fig. 3). At least two
independent transgene lines were generated for each con-
struct. Ectopic expression was carried out by using the
GAL4/UAS binary system (Brand et al., 1994; van Roessel
and Brand, 2000). Flies bearing GAL4 driver transgenes
that produce GAL4 protein either ubiquitously (Actin5C or
HSP70) or in restricted fashion were crossed to responder
flies carrying the GAL4-UAS:snr1 transgenes. At least 30
different GAL4 driver lines were tested in this fashion with
2 independent snr1 responder lines carrying the same trans-
gene construct. The effects of snr1 gene dosage on expres-
sion phenotypes were assessed in flies bearing the responder
transgenes together with a snr1 null allele (snr1R3). All
crosses were performed at 29°C unless otherwise indicated.
Expression of each transgene was determined by Western
blot using extracts from embryos (0–24 h after egg laying)
or pupae (24–48 h after pupariation) as described previ-
ously (Zraly et al., 2002). Whole cell, cytoplasmic, and
nuclear extracts were prepared (Moritz, 2000; Pazin, 2000)
from pupae ubiquitously expressing SNR-1, SNR1-2, or
control pupae raised at 29°C. Proteins were fractionated by
SDS–PAGE, blotted, and probed with anti-SNR1 and anti-
tubulin (Babco) antibodies. Immunoprecipitations of SNR1,
SNR1-2, and BRM were performed by using embryonic
extracts as described (Dingwall et al., 1995).
Production of antibodies and immunostaining
Affinity purified rabbit polyclonal SNR1 antiserum was
produced by immunizing rabbits with a full-length (aa
2–370) SNR1:HIS fusion (produced in pTrcHis; Invitro-
gen). SNR1-specific antibodies were affinity purified by
using the SNR12–370:HIS fusion bound to AminoLink resin
(Pierce Endogen, Inc). Controls for SNR1 antibody speci-
ficity included testing different portions of SNR1 expressed
in bacteria as fusion proteins, with all regions capable of
being recognized (data not shown). Also, third instar larvae
carrying a heat-inducible snr1 cDNA rescue transgene
(hsp70-snr1) were heat-shocked for 60 min followed by a
30-min recovery. Both heat-shocked and control larvae
were dissected in 1  PBS, 0.1% Triton X-100 (PBST) and
fixed, and imaginal discs were immunostained with the
SNR1 antibody. BRM-specific antibodies (4449.3) were
raised in rabbits immunized with an amino-terminal frag-
ment of the BRM protein fused to GST (GST:BRM3–100)
and affinity purified.
Third instar Oregon R larvae raised at 25°C were dis-
sected in PBST and fixed, and tissues were immunostained
with anti-SNR1 or anti-BRM antibodies diluted in PBSTB
(1 PBS, 0.1% Triton X-100, 0.2% BSA). Ovaries from 4
days post-eclosion wild type females held on fresh yeast
were dissected in Ringer’s, fixed (Matthies et al., 2000), and
immunostained with anti-SNR1 antibody. Donkey anti-rab-
bit HRP secondary antibodies (Jackson ImmunoResearch)
were used for detection. Immunolocalization of SNR1,
BRM, and RNA PolII on third larval instar salivary gland
polytene chromosomes was performed with affinity-purified
primary antibodies (-SNR1, 1:100; -BRM, 1:250 diluted
in blocking solution). The goat -RNA PolII gAP alpha-D1
antibody (gift of A. Greenleaf) recognizes RpII140, the
second largest subunit of Drosophila PolII (IIc) as described
(Skantar and Greenleaf, 1995) and was used at a dilution of
1:100 in blocking solution. Polytene chromosome immuno-
staining was performed as described (Zink and Paro, 1989,
1995) with detection carried out using Cy-3-conjugated
donkey anti-rabbit (1:350) or Cy-2-conjugated donkey anti-
goat (1:100) secondary antibodies (Jackson ImmunoRe-
search) diluted in block solution supplemented with 2%
normal donkey serum.
PEV analysis
Females carrying a variegating allele of the white gene
(wm4h) were crossed to males carrying mutations in Brm
complex genes or controls and incubated at 25°C. Newly
eclosed nonbalanced male progeny were selected and held
for 3 days at 25°C, then stored at 80°C. Heads from 20
males per sample (with at least 2 replicate samples) were
homogenized in 50 l of acidified ethanol (30%, pH 2.0),
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then the volume was raised to a total of 1500 l. Extractions
were incubated in the dark at 25°C for 48 h, then pigments
were quantified by absorbance at 480 nm. snr1 mutants used
for this assay were derived from P-excisions and included
nonsense (snr1R3), internal deletion (snr1SR21), deficiency
(snr1SR71), and viable precise excision (snr1PIrev) alleles
(Dingwall et al., 1995).
Results
Characterization of snr1 mutant alleles
Existing mutant alleles of snr1 include a P-element in-
sertion (snr1P1) and a P-excision truncation (snr1R3). Both
disrupt SNR1 at aa 131, eliminating most of the highly
conserved regions, and result in recessive lethality during
the late first or early second larval instar stage (Dingwall et
al., 1995; Zraly et al., 2002). An 8.9-kb snr1 genomic
fragment was isolated and cloned into pCaSpeR-hs to gen-
erate rescue transgenes located on either the first or second
chromosomes. Transgenes on either chromosome could res-
cue the recessive lethality (data not shown). Heat shock
expression of a full-length snr1 cDNA was also capable of
rescuing lethality; however, rescued flies exhibited signifi-
cantly shortened life spans (5 days post-eclosion). Al-
though these alleles are likely nulls, we repeated the P-
mobilization screen to generate small deficiencies. Among
nearly 150 excision lines, we identified a small internal
deletion of snr1 (snr1SR21) and two small deficiencies sur-
rounding the snr1 gene (snr1SR29, snr1SR71). The snr1SR21
lethality was rescued by a genomic transgene while the
deficiency lines were not, indicating that the deletions re-
moved other vital genes. Sequencing of the snr1SR21 muta-
tion revealed a 237-bp deletion and frame shift, truncating
SNR1 at Thr133. In genetic tests, snr1SR21 behaved as a null
(data not shown). Southern blots of snr1SR29 and snr1SR71
strains revealed deletion of snr1 and portions of the sur-
rounding genomic DNA.
A noncomplementation (EMS) screen identified four
new recessive lethal alleles of snr1 (Zraly et al., 2002) that
failed to complement both snr1R3 and snr1SR21. All were
rescued as heterozygotes in trans with snr1R3 and as ho-
mozygotes. Homozygous and trans-heterozygous mutant
combinations exhibited lethality at the end of the first (L1)
or early second (L2) larval instar stage with no obvious
developmental defects. Sequencing (Fig. 1) revealed that E2
resulted from a 31-bp insertion; including a direct duplica-
tion of 10 bp, likely caused by insertion then imprecise
excision of a mobile element. The inserted DNA produces
an in-frame stop (TGA) at aa 134, close to the position of
our lethal P-insertion, suggesting a transposition hotspot.
The E3 mutation deletes the region encoding aa 137 to aa
243, including Repeat 1, although the open reading frame
remains intact; E4 is a single base change (G/A) at the snr1
intron 5 splice donor site. While a cryptic splice site might
be used, this seems unlikely as there is no other consensus
5 donor site and failure to splice properly would lead
immediately to a TAA stop codon following aa 91. Char-
acterization of the snr1E1 allele is reported elsewhere
(Marenda et al., 2003).
The molecular weights of the predicted SNR1R3 (14.4
kDa), SNR1E2 (14.6 kDa), SNR1E3 (29 kDa), and SNR1E4
(10 kDa) proteins are significantly smaller than the native
SNR1. Extracts from heterozygous snr1E2, snr1E3, and
snr1E4 mutant pupae were tested by Western blot. Poly-
clonal antibodies to SNR1 recognize a prominent 45-kDa
species representing wild-type protein (Fig. 1) and are ca-
pable of recognizing the predicted mutant proteins (data not
shown). None of the snr1 alleles tested produced any de-
tectable protein (Fig. 1, and data not shown), indicating that
all are null mutations.
Maternal and zygotic SNR1 functions are essential
To examine tissue-specific snr1 loss-of-function pheno-
types, recombinant chromosomes were generated to pro-
duce somatic and germline clones by using the FLP/FRT
system (Chou and Perrimon, 1996; Golic, 1991; Xu and
Rubin, 1993). Somatic cell-derived snr1 mutant clones were
generated in both a brm and a brm2 heterozygous mutant
background. The size and frequency of the snr1 clones were
compared with controls, either non-heat-shocked siblings or
clones generated from FRT-only chromosomes. A total of
1165 snr1 clones were scored and compared with 375 con-
trol clones (Table 1). Mutant clones were more frequently
observed at late larval stages and clone sizes were generally
larger when induced during L3 compared with L2, possibly
indicating that snr1 mRNA and protein produced during the
L1 and L2 stages might persist to allow for continued cell
division after clone induction. However, both frequency and
size were reduced relative to control clones, revealing that
snr1 was important for cell viability. Mutant clones gener-
ated in a heterozygous brm2 background were less fre-
quently observed, and clone sizes were reduced compared
with both brm and control clones induced at similar stages,
suggesting an additive effect between brm and snr1.
Examination of snr1 clones in the abdomen revealed a
strong similarity with previously described brm clones
(Elfring et al., 1998), including duplicated, fused, or mal-
formed (stunted, twisted or bent) mechanosensory bristles
(Fig. 2). Within snr1 clone boundaries, but not controls,
patches of tissue were observed that were missing bristles
and/or bristle sockets; however, no homeotic transforma-
tions were observed. Consistent with brm mutant clones, the
loss of snr1 appears to affect peripheral nervous system
development. Unlike brm clones, snr1 clones exhibited cu-
ticle defects within the abdominal segments, including fu-
sion of adjacent segments within clones, loss of pigmenta-
tion, and cuticle disruptions (65% of clones scored). The
presence of a heterozygous brm2 null allele enhanced the
snr1 clone phenotype in the abdomen, suggesting a role for
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the Brm complex in histoblast proliferation. Production of
snr1 clones exclusively in the eye imaginal discs (Stowers
and Schwarz, 1999) revealed only slightly reduced eye
sizes, but no significant morphological defects (data not
shown). Few clones were obtained in the head region under
any of the conditions tested, and clones on the dorsal thorax
only revealed minor shortening of bristles within the clone
boundaries, but no other bristle or homeotic phenotypes.
Thus, although brm is important for the development of the
thorax (Elfring et al., 1998), clones of snr1 did not reveal
any clear role. Unlike brm clonal analyses, in an examina-
tion of 1600 legs in which snr1 clones were produced
(including a brm-sensitized background), we did not ob-
serve any obvious phenotypes and clones appeared with a
frequency similar to controls (data not shown). As the ma-
ternal contribution of snr1 is sufficient for the completion of
development through the early larval stages (Dingwall et al.,
1995), it is possible that snr1 mRNA or protein might
persist from expression earlier in development masking
potential loss-of-function thoracic phenotypes, and/or that
snr1 may not be critically required for all Brm complex
functions.
In contrast to mutant alleles of brm, mor, and osa that
revealed critical requirements for the Brm complex in em-
bryogenesis, snr1 null mutants die as early larvae with no
obvious defects. Thus, either the large maternal contribution
of snr1 mRNA is sufficient to allow for normal embryonic
development or snr1 is not required for all Brm complex
functions in embryos. To examine possible embryonic roles
for snr1, female germ cells lacking snr1 gene product were
generated by using the FLP/FRT system combined with the
ovoD1 dominant female sterile mutation that blocks oogen-
esis (Chou et al., 1993). Heat-shock-induced expression of
the FLP recombinase during both the first and third larval
instar stages allowed for recombination between the
FRT[82B], P[ovoD1] and FRT[82B], snr1R3 chromosomes
producing females with homozygous snr1 mutant germline
cells that had lost the ovoD1 mutation. A total of 32 females
were examined and all were found to be infertile, producing
no eggs. Control flies of the genotype FRT[82B], P[ovoD1]/
Table 1
Somatic clonal analysis of snr1R3
Structure No. clones/structures scored Frequency Size Percent of
abnormal bristlesa
Non-HS L1 L2 L3 Non-HS L1 L2 L3 L1 L2 L3 L1 L2 L3
A. FRT[82B], snr1R3
Head 0/20 2/27 3/18 56/122 0 0.07 0.16 0.45 1.0 1.0 1.0 0 0 100
Dorsal thorax 1/20 9/27 7/18 225/122 0.05 0.33 0.39 1.84 1.0 1.14 2.55 28 0 90
Abdomen 5/20 52/27 83/18 497/122 0.25 1.9 4.6 4.1 1.39 2.7 3.08 85 54 77
B. brm2 FRT[82B], snr1R3
Head 0/25 3/32 0/21 11/59 0 0.09 0 0.19 1.0 — 1.3 0 — 71
Dorsal thorax 4/25 4/32 0/21 27/59 0.16 0.13 0 0.46 1.5 — 1.85 75 — 100
Abdomen 5/25 20/32 40/21 126/59 0.20 0.63 1.90 2.14 2.5 1.63 2.10 100 100 100
C. FRT[82B] control
Head 1/41 0/20 0/20 10/21 0.02 0 0 0.48 — — 1.11 0 0 0
Dorsal thorax 3/41 1/20 29/20 82/21 0.07 0.05 1.45 3.90 2.45 7.10 4.20 0 0 0
Abdomen 19/41 2/20 57/20 124/20 0.46 0.10 2.85 5.90 1.50 3.90 4.20 0 0 0
a Abnormal bristles within the abdomen were broadly defined as any deviation from wild type, including shortened, twinned, missing, bent or malformed.
The primary mutant phenotype observed within clone boundaries on the dorsal thorax was the appearance of slightly shortened bristles relative to wild type.
Fig. 2. Mosaic clones of snr1 reveal bristle-patterning defects. (A) Abdominal
cuticle disruptions and malformed bristles (arrow) are observed in snr1 mosaic
clones. (B) Stunted and duplicated bristles in a snr1 clone on the abdomen.
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FRT[82B] produced germline mosaic females that were
fully fertile (7 out of 7 examined; 198 total eggs produced).
Consistent with the heat-shock cDNA rescue results, where
all rescued females were infertile once snr1 product was no
longer produced (20 females tested, 0 eggs produced),
germline clone analyses revealed that snr1 is required for
oogenesis.
Late developmental functions of snr1
Ectopic expression of brm and osa has proven useful for
examining potential Brm complex functions in larval tissues
(Collins et al., 1999; Elfring et al., 1998). To disrupt SNR1
functions in specific tissues, deletions of the snr1 cDNA
removing one or both of the conserved repeat regions (Fig.
3), as well as a full-length cDNA, were placed under the
control of a GAL4 responsive enhancer, and independent
viable transgene lines were generated. Each construct was
tested for expression and examined for phenotypes follow-
ing GAL4 induction. The SNR1-1 and SNR1-2 proteins
were stably expressed at elevated levels relative to wild-
type SNR1 based on Western blots probing extracts ob-
tained from P[w, snr1]/Act5C-GAL4 (II) embryos (Fig.
3); however, the SNR1-3 and SNR1-4 proteins were too
small or unstable to be detected (data not shown). Although
expression of SNR1 is normally restricted to the CNS and
brain in late embryos and imaginal tissues in larvae, expres-
sion of SNR1-1 with 30 different tissue-specific and ubiq-
uitous GAL4 driver lines had no obvious mutant phenotype,
suggesting that SNR1 had no significant function indepen-
dent of the Brm complex. Expression of large SNR1 dele-
tions (SNR1-3, SNR1-4) with a variety of GAL4 drivers did
not produce specific phenotypes, indicating that the trun-
cated proteins did not interfere with normal SNR1 function,
consistent with existing snr1 null alleles that are fully re-
cessive.
In contrast, ectopic expression of SNR1-2 showed sig-
nificant developmental defects. The GAL4 driver-depen-
dent phenotypes included specific wing vein disruptions
(Table 2; Fig. 3C and D), incomplete abdominal tergite
fusion along the dorsal midline (Fig. 3F–H), both general
and male-specific lethality, and a decrease in adult longevity
Fig. 3. SNR1 is important for wing and abdomen development. (Left) SNR1 full-length (SNR1-1) or deletion transgene constructs (SNR1-2, -3, -4) were
expressed under GAL4 control. (Right) SNR1-2 is under stringent control, induced only by coexpression of GAL4 in transgenic flies. Western blot analysis
using anti-SNR1 antibody revealed the 45-kDa SNR1 protein in both uninduced (U) and induced (I) extracts and the 29-kDa SNR1-2 protein only in the
induced extracts. SNR1-2 expression phenotypes include L2 wing vein disruptions (A, B) and incomplete dorsal abdomen fusion (D–F). A wild type female
abdomen is shown in (C). Severity correlates with temperature: () at 18°C (D), () at 25°C (E), and () at 29°C (F).
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(Fig. 4). In each case, the penetrance and severity correlated
with snr1 dosage (/  /) and temperature of incu-
bation. Similar results were obtained by using two indepen-
dent UAS:snr1-2 transgene lines.
Ectopic expression of SNR1-2 in developing wing tis-
sues using P[GaWB]69B-GAL4 resulted in the appearance
of ectopic mechanosensory bristles, disruption of the L2
longitudinal vein (Fig. 3), and an ectopic bristle on the distal
portion of the L3 vein (30% of wings examined). Typically,
the L3 vein has three sensilla and no bristles. Vein-specific
effects have been observed with expression of the domi-
nant-negative brmK804R and portions of osa (Collins et al.,
1999; Elfring et al., 1998). Unlike brm and osa, snr1 func-
tion does not appear to be generally limiting in the dorsal
thorax, legs, and head regions. However, expression of
SNR1-2 in the abdomen during late development using
P[e22c-GAL4] resulted in lethality at 29°C in a snr1 (/)
background (Table 2) and significant cuticle disruption,
including incomplete fusion of the tergites along the dorsal
midline (Fig. 3E–H). Heat-shock GAL4-induced expression
of SNR1-2, but not SNR1-1, also resulted in lethality (data
not shown), confirming that expression of the truncated
protein disrupted normal SNR1 functions.
Ubiquitous expression of SNR1-2 using Actin5C-GAL4
showed similar patterning defects and resulted in additional
phenotypes. Over 70% of females (N 	 101) of the geno-
type w; Act5C-GAL4/UAS:snr1-2, snr1R3 were sterile, com-
pared with 11% of control females (N 	 45) under identical
conditions. Surprisingly, ubiquitous expression of SNR1-2
also resulted in a significant decrease in adult lifespan (Fig.
4). Adults of the genotype Act5C-GAL4/UAS:snr1-2, snr1R3
exhibited a rapid decrease in viability following eclosion,
and the effect was more pronounced among male progeny.
These results were verified by using a second Act5C-GAL4
insertion on chromosome (II), with even greater disparities
in the sex ratio among progeny of the genotype Act5C-
GAL4;UAS:snr1-2, snr1R3 (9:1 female; N 	 131).
To examine whether the SNR1-2 phenotypes arose from
disruption of Brm complex assembly/function or repre-
Table 2
Abdomen and wing phenotypes resulting from SNR1-2 expression
Temp Genotype Total
flies
Percentage showing phenotype
Abdomen Wing
None    L2 vein disrupt L3 bristle
18°C UAS:snr1-2a/e22c-GAL4; snr1R3/ 31 32 26 16 26
UAS:snr1-2a/e22c-GAL4; /TM6B 21 67 24 9 0
Control siblings 46 100 0 0 0
UAS:snr1-2a; GaWB-69B/snr1R3 82 0 0
UAS:snr1-2a; GaWB-69B/TM6B 72 0 0
25°C UAS:snr1-2a/e22c-GAL4; snr1R3/ 44 43 18 18 21
UAS:snr1-2a/e22c-GAL4; /TM6B 44 82 11 5 2
Control siblings 96 100 0 0 0
UAS:snr1-2a; GaWB-69B/snr1R3 94 2 5
UAS:snr1-2a; GaWB-69B/TM6B 102 0 0
29°C UAS:snr1-2a/e22c-GAL4; snr1R3/ 0 0 0 0 0
UAS:snr1-2a/e22c-GAL4; /TM6B 96 12 32 23 32
Control siblings 155 100 0 0 0
UAS:snr1-2a; GaWB-69B/snr1R3 65 54 25
UAS:snr1-2a; GaWB-69B/TM6B 68 0 0
GaWB-69B/UAS:snr1-2b, snr1R3 28 25 36
Fig. 4. SNR1 is required for sustained adult viability. Percent viability
decreased significantly over time at 29°C for flies ubiquitously expressing
SNR1-2. The decreased lifespan was more pronounced in males (15%
viable) relative to females (35% viable) and wild type controls (88%
viable) at 14 days post-eclosion.
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sented dominant-negative effects specific to SNR1, we
tested for incorporation of SNR1-2 into the Brm complex by
coimmunoprecipitation with BRM. Consistent with earlier
reports (Collins et al., 1999; Dingwall et al., 1995; Papoulas
et al., 1998), the wild type SNR1 coprecipitated with BRM,
and we found that BRM could efficiently coprecipitate with
SNR1 (Fig. 5A). The stoichiometry of SNR1 and BRM
coprecipitation was similar, using antibodies to either pro-
tein (compare Fig. 5A and B), suggesting that most SNR1
was in complexes with BRM. Extracts prepared from P[w,
UAS:snr1-2]/Act5C-GAL4 (II) embryos were incubated
with antibodies to BRM, fractionated, and probed with
antibodies to SNR1. Importantly, a portion of the SNR1-2
protein was found within Brm complexes (arrow in Fig.
5B).
A nuclear export signal (NES) in INI1, when unmasked
by C-terminal deletions, allows for hCRM1-dependent ex-
port in cultured cells that may be important for cellular
immunity (Craig et al., 2002; Turelli et al., 2001). The NES
sequence is strongly (13/14 residues) conserved in SNR1,
and the SNR1-2 deletion removes residues immediately
C-terminal to the NES sequence (Fig. 5C). As the majority
of SNR1-2 was not found in complexes with BRM, we
examined whether the protein was properly localized. Ex-
tracts prepared from pupae that ubiquitously expressed ei-
ther SNR1-1 or SNR1-2 and from uninduced controls were
fractionated and probed with antibodies to SNR1 and tubu-
lin (Fig. 5D). While the majority of endogenous SNR1 and
SNR1-1 protein was found in the nucleus as expected,
SNR1-2 was significantly elevated in the cytoplasm. Thus,
overexpression does not affect SNR1-1 localization and the
NES sequence can confer nuclear export in vivo when
unmasked by the deletion of C-terminal residues. Further,
BRM localization was not affected following induction of
SNR1-2 (data not shown), suggesting that the SNR1-2 phe-
notypes were the result of dominant interference with nor-
mal SNR1 function in the nucleus and/or that the SNR1-2
protein in the cytoplasm affected unknown processes. As
the SNR1-2 phenotypes are sensitive to snr1 dosage, the
nuclear functions of SNR1 are most likely to be impacted;
however, gain-of-function cytoplasmic functions of SNR1-2
are possible.
Fig. 5. SNR1-2 is incorporated into the Brm complex and is mislocalized to the cytoplasm. (A) SNR1 is stoichiometric with BRM in anti-SNR1 immune
precipitates from embryonic extracts. Lanes: -Ab, G-Sepharose control with no primary antibody (lane represents 50% of pelleted material); E, 100 g
extract; S, supernatant fraction (lane represents 20% of input protein extract); P, pellet fraction (lane represents 50% of coimmunoprecipitated proteins). (B)
SNR1 and a portion of SNR1-2 coimmunoprecipitate with BRM. The arrow indicates the position of SNR1-2 (29 kDa) in the precipitated material. The
stronger signal at 25 kDa may represent a SNR1-2 degradation product; although a cross-reacting band of similar molecular mass is seen in the (Ab)
control, though not in the extract or supernatant lanes. (C) A conserved nuclear export signal (NES) is present in both SNR1 and INI1. The SNR1-2 protein
terminates immediately following the NES sequence. (D) SNR1-2 mislocalizes to the cytoplasm. Equal amounts of total (T), cytoplasmic (C), and nuclear
(N) extracts prepared from pupae expressing SNR1-1 and SNR1-2 or control pupae were probed with anti-SNR1 and anti-tubulin antibody.
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Developmental expression of snr1
The SNR1-2 expression phenotypes reflect disruption of
late larval/early pupal development, suggesting critical Brm
complex functions in metamorphosis. We therefore reexam-
ined the snr1 mRNA profile with emphasis on late devel-
opment using highly specific riboprobes (data not shown).
We previously found snr1 mRNA present at every devel-
opmental stage, with the highest levels observed in early
embryos, pupae, and virgin females (presumably in oo-
cytes), contrasting with lower levels in late-staged embryos
and larvae (Dingwall et al., 1995). Using snr1 riboprobes,
we observed a transient increase in mRNA in late third
instar larvae and again in pupae, coincident with rising titers
of the molting hormone 20-hydroxyecdysone that regulates
metamorphosis. Unexpectedly, we also observed detectable
snr1 mRNA in adult males (data not shown). Thus, there is
significant expression of snr1 mRNA in adults and during
developmental periods that show susceptibility to expres-
sion of SNR1-2.
To better define the developmental distribution of SNR1
in specific tissues, affinity-purified antibodies were used to
detect the protein in third instar larval imaginal discs, sali-
vary glands, and adult ovaries. As a control to determine
whether the SNR1 polyclonal antiserum directed against the
full-length protein (see Materials and Methods) was capable
of detecting the protein in all tissues, SNR1 was produced
ectopically in third instar larvae by using a hsp70-snr1
cDNA transgene. Following a 60-min heat-shock with a
30-min recovery, imaginal discs were dissected, fixed, and
immunostained. In heat-shocked, but not control larvae,
high level expression of SNR1 was detected in all imaginal
tissues, including the leg and wing discs (Fig. 6A), confirm-
ing the specificity of the antibody.
SNR1 and BRM are ubiquitously expressed in early
embryos, with late embryonic expression generally re-
stricted to the CNS and brain (Dingwall et al., 1995;
Elfring et al., 1998). In striking contrast, SNR1 was not
detected in most cells of the larval CNS and brain, with
only a few cells in the optic lobe expressing the protein
(Fig. 6B). SNR1 was only present at detectable levels in
a subset of cells of the leg and wing discs, if at all (Fig.
6C and E vs 6D and F). Consistent with a genetic role for
snr1 in eye disc development (Brumby et al., 2002),
SNR1 was present at high levels in the eye disc both
anterior and posterior to the morphogenetic furrow (MF),
as well as the developing photoreceptor cells (Fig. 6G
and G). SNR1 was also present in salivary gland nuclei,
where it was associated with the polytene chromosomes
(Fig. 6H–I); although, it was found at higher levels in
imaginal cells compared with polytene cells of the sali-
vary gland and gut tissues. SNR1 expression was ob-
served in a subset of cells within the ovariole (Fig. 6J and
K), specifically in the posterior portion of the germarium
(regions 2 and 3), a few cells of the somatic follicular
sheath, at low levels in nuclei of the nurse cells, and the
developing oocyte. Therefore, SNR1 is present in cells
that exhibit somatic and germline clone null phenotypes
and are sensitive to the expression of SNR1-2. The ab-
sence of detectable SNR1 in cells of the leg imaginal
discs that express high levels of BRM suggests that
SNR1 is an essential component of a subset of Brm
complexes.
BRM and OSA associate with polytene chromosomes at
many sites (Collins et al., 1999), including less condensed
interband regions that generally correspond to actively tran-
scribed genes, suggesting that the Brm complex might have
a primary role in opening chromatin to allow for transcript
initiation at many gene loci. To address this question di-
rectly, we examined the localization of SNR1, BRM, and
RNA PolII on the salivary gland polytene chromosomes
(Fig. 7). Both SNR1 and BRM were broadly distributed at
many sites in essentially identical patterns and at signifi-
cantly higher levels in the interband regions, nearly coinci-
dent (90%) with RNA PolII (Fig. 7D and H). In addition,
neither the Brm complex nor PolII was found significantly
associated with the BX-C homeotic cluster, a known in vivo
target of the Brm complex that is inactive in this tissue. The
largely overlapping localization patterns suggest that sites
of Brm complex accumulation coincide with actively tran-
scribed loci, although we are unable to determine the precise
step at which the Brm complex interfaces with the transcrip-
tion machinery as the PolII antibody recognizes both elon-
gating and promoter bound forms (Skantar and Greenleaf,
1995). Importantly, the SNR1 and BRM proteins did not
entirely colocalize with PolII. In particular, the relative
intensity of PolII staining at specific sites (indicated by
colored arrows in the figure) differed from either BRM or
SNR1. Conversely, BRM and SNR1 also accumulated at
locations not associated with PolII. Our data indicate that
the Brm complex is widely present at actively transcribed
loci, perhaps to facilitate aspects of gene activation or main-
tenance. However, while transient interactions could not be
ruled out, the Brm complex is not a constitutive component
of all PolII complexes in vivo and raises the possibility that
the Brm complex has opposite functions to PolII at specific
target genes.
snr1 functions as both an activator and repressor
A heterozygous snr1R3 mutant shows no obvious ge-
netic interaction with the Pc gene, although it moderately
enhances a trx mutant phenotype and shows weak inter-
action with some brm and osa alleles (Collins et al.,
1999; Dingwall et al., 1995). In addition, snr1R3 can
suppress (50%) the antennal-to-leg transformation of
the dominant AntpNs mutation (data not shown), similar
to the suppression observed with brm, mor, and osa
(Brizuela and Kennison, 1997; Tamkun et al., 1992;
Vazquez et al., 1999). Several trx-G genes (including
brm, mor, and osa) can influence the expression of a
variegating white minigene under the influence of the Scr
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(HOM gene) enhancers carried on the same transgene
construct (Gindhart and Kaufman, 1995). Using the same
assay with a snr1R3 null allele, we found that snr1 was
necessary to maintain active transcription of the white
minigene (data not shown). Thus, snr1 can affect HOM
gene expression as a coactivator of transcription.
The wide distribution of SNR1 and BRM on polytene
chromosomes raised the possibility that the Brm complex
Fig. 6. SNR1 is restricted to a subset of BRM-expressing tissues. (A) Third instar larval wing and leg discs immunostained with anti-SNR1 following a 60-min
heat-shock of an hsp70-snr1 cDNA. High levels of SNR1 were detected in all larval discs. (B) SNR1 expression in the larval brain is restricted to the optic
lobe. Immunolocalization of SNR1 and BRM in similarly staged third instar larval leg (C, D) and wing (E, F) imaginal discs. BRM (C, E) is expressed in
all cells of the leg and wing discs, with elevated levels in the developing wing pouch. SNR1 (D, F) is not present at high levels in the T1/T2 leg discs (D),
T3 leg disc (F, upper right), or the wing notum. (G, G) Expression of SNR1 in the eye disc. The morphogenetic furrow (MF) and anterior/posterior (a/p)
orientations are indicated in (G, G). A magnified view of an eye disc region (G) showing cells both anterior and posterior to the morphogenetic furrow
(arrowhead) reveal high level expression of SNR1 in all cells except those arrested in G1 phase within the furrow. (H, I) SNR1 is present in salivary gland
nuclei. Shown in (I) is a magnified view of a single salivary gland nucleus (100 magnification). Note the punctate staining associated with the chromosomal
DNA. (J, K) SNR1 is expressed at high levels in regions 2 and 3 of the germarium, though SNR1 is found at significantly lower levels in the somatic follicular
sheath and developing oocyte.
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might globally affect gene expression. We examined the
influence of Brm complex genes on the expression of a
variegating allele of the white gene, wm4h (Dorn et al., 1993;
Reuter and Wolff, 1981). This test of position effect varie-
gation (PEV) measures the quantitative effects of chromo-
somal position and higher order structure on gene expres-
sion (Wakimoto, 1998; Wallrath and Elgin, 1995). An
E(var) mutation enhanced the variegation of wm4h (Fig. 8A
and B), whereas snr1 suppressed the variegating phenotype
of wm4h (Fig. 8C). A snr1R3/E(var)3–4 combination resulted
in intermediate variegation (Fig. 8D). Quantitative pigment
assays were performed by using (20) male flies heterozy-
gous for Su(var)205, E(var)3–4, and various Brm complex
gene mutations that also carried the wm4h allele. Flies het-
erozygous for snr1 mutations, including snr1R3, snr1SR21,
snr1SR71, snr1E2, and snr1E3 as well as a brm2, snr1R3
recombinant exhibited a strong suppression of the variegat-
ing phenotype (Fig. 8, and data not shown); however, mu-
tations in Brm complex genes alone had little effect, or
possibly a slight enhancement. As a control for genetic
background effects on variegation, a viable precise excision
of the P-transposon (Dingwall et al., 1995) that was used to
derive the snr1 mutant alleles was tested in parallel, with no
difference in pigment levels observed between the snr1PIrev
and the wm4h control males (data not shown). Thus, snr1 is
epistatic to a known enhancer of variegation in this assay,
suggesting that SNR1 may directly regulate certain func-
tions of the Brm complex.
Discussion
Our genetic analyses of new snr1 mutant alleles, ectopic
expression of deletion transgenes, and developmental stud-
ies demonstrate that SNR1 is critically required for oogen-
esis, proper wing, abdomen, and nervous system develop-
ment, and for sustained adult viability. SNR1 is highly
conserved with counterparts in yeast (SNF5) and mammals
(INI1) and is a component of the Drosophila Brm (SWI/
SNF) complex purified from embryos. It serves as an es-
sential subunit for some Brm complex activities; however,
SNR1 appears to be an optional component. In particular,
we found that snr1 was not genetically required for proper
leg morphogenesis and that SNR1 was not expressed at
detectable levels in the late larval leg discs, despite strong
evidence for essential Brm complex functions in regulating
leg development (Collins and Treisman, 2000; Kennison
and Tamkun, 1988; Tamkun et al., 1992).
While the biological functions of SNR1 and INI1 are
complex, both are essential for development. Specifically,
genetic analyses of both snr1 null and conditional mutants
and disrupting SNR1 function with dominant negative
Fig. 7. SNR1 and BRM frequently colocalize with PolII on salivary gland polytene chromosomes. Immunolocalization of PolII (B, F), SNR1 (C), and BRM
(G) reveals broad distribution at many sites predominantly within interbands. Colocalization of SNR1 with PolII (D) and BRM with PolII (H) at 90% of
sites. Green arrows indicate sites of strong PolII and weak or absent SNR1/BRM staining, while red arrows indicate sites of strong SNR1/BRM staining and
weak or absent PolII staining. Shown is the position of the BX-C, a known Brm complex target. No strong PolII, SNR1, or BRM signals are detected at this
locus, which is inactive in salivary gland nuclei. DAPI-stained preparations of the same chromosomes are shown in (A, E).
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transgenes have shown that SNR1 is required at all devel-
opmental stages and in adults, though in a restricted set of
tissues. Disruption of INI1 function blocks early murine
embryogenesis at the peri-implantation stage (E3.5), and
chimeric mice harboring an ES cell-derived INI1 knockout
develop tumors of the central nervous system and soft tissue
sarcomas at high frequency (30%) (Klochendler-Yeivin et
al., 2000), suggesting cell lineage specificity. Moreover,
mutations in INI1 are strongly (90%) associated with
aggressive childhood cancers (Sevenet et al., 1999; Ver-
Fig. 8. snr1 functions as a suppressor of wm4h variegation. Relative eye pigmentation observed in flies of the following genotypes: wm4h;/ (A),
wm4h;E(var)3–4/ (B), wm4h;snr1R3/ (C), wm4h;E(var)3–4/snr1R3 (D). (Bottom) Quantitative pigment assays (absorbance units at 480 nm) from male wm4h
flies carrying heterozygous mutant alleles of the genes shown.
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steege et al., 1998), suggesting a critical role in restricting
cell growth, a role we have demonstrated for snr1 as well
(Marenda et al., 2003).
Developmental requirements for snr1 function
A single snr1 transcript is present at all developmental
stages and in adults (Dingwall et al., 1995). SNR1 protein
and RNA levels fluctuate during development, with ele-
vated expression in specific tissues. Our genetic studies of
snr1 revealed that null alleles caused early larval lethality.
However, both snr1 germline clones and maternal expres-
sion of SNR1-2 caused female sterility and late embryonic
lethality, implying both a critical role in early development
and that a large maternal contribution of snr1 mRNA was
sufficient for embryogenesis. An unexpected result of our
studies was the finding of an important role for SNR1 in
sustained adult viability, including males. Consistent with
this view, we found snr1 mRNA present in male flies (our
unpublished results); moreover, both mor mRNA (Crosby et
al., 1999) and BRM protein (Elfring et al., 1998) have been
found in adult males, raising the possibility that the Brm
complex may be continuously required.
The snr1 somatic and germline clone phenotypes largely
overlap with those observed for brm (Elfring et al., 1998),
and effects caused by expression of interfering transgenes
suggest that snr1, brm, and osa are important for proper
wing development. Phenotypic differences likely reflect
unique tissue-specific functions for snr1. For example, anal-
ysis of somatic clones revealed that snr1, like brm, was
required for proper peripheral nervous system development,
as both snr1 and brm mutant clones exhibited twinned,
missing, stunted, and fused bristles in the abdomen remi-
niscent of abnormalities associated with mutations in neu-
rogenic genes, such as Notch (Hartenstein and Posakony,
1990).
Both somatic clonal analyses and ectopic expression of
SNR1-2 revealed that histoblast proliferation was strongly
compromised when functional snr1 was limiting, and the
snr1 somatic clone phenotype was enhanced by the pres-
ence of a brm mutation, suggesting important functions for
the Brm complex in histoblasts. Clusters of histoblasts
within each segment produce the integument of the adult
abdomen on both the dorsal and ventral surfaces. The his-
toblasts proliferate during pupal development, with division
initiated shortly after pupariation (AP) and the commence-
ment of migration at about 14 h AP (Fristrom and Fristrom,
1993). Fusion of the different anterior and posterior dorsal
histoblast nests that produce the tergite occurs between 18
and 40 h AP. The fusion of the dorsal cuticle was most
severely affected by expression of SNR1-2 that correlated
with both the temperature of incubation and the snr1 dos-
age, suggesting that SNR1 serves to guide Brm complex
functions in the developing histoblasts. Although the genes
regulated by snr1 are unknown, one possibility is the es-
cargot gene that encodes a zinc-finger protein required for
maintaining a diploid state in imaginal cells and normal
development of the abdomen (Fuse et al., 1994; Hayashi,
1996; Hayashi et al., 1993). High-level expression alone
could not account for the SNR1-2 phenotypes, as SNR1-1
and rescue transgenes had no effect. While formally possi-
ble, it appears unlikely that SNR1 has normal functions
independent of the Brm complex.
In addition to the bristle defects observed in snr1 clones,
expression of SNR1-2 disrupts normal wing vein patterning
and PNS development. The observed defects all coincide
with a developmental period in late larvae and early pupae
associated with rapid cell proliferation and differentiation
and closely correlate with increased expression of Brm
complex genes. Of possible significance, snr1 mRNA ex-
pression fluctuates coincident with transient pulses of ecdy-
sone in late development (our unpublished results), espe-
cially as the SWI/SNF complex can assist the activation
potential of other steroid hormone-binding transcription fac-
tors (Peterson and Workman, 2000). Similar to expression
of BRMK804R that disrupts ATPase activity in vivo but not
the formation or stability of the complex, the expression of
SNR1-2 resulted in specific wing vein patterning defects,
including disruptions along the L2 vein and ectopic bristles
on the L3 vein. Although some of the misexpression phe-
notypes overlap, the SNR1-2 effects were most striking in
anterior wing veins (L2 and L3), while BRMK804R pheno-
types affected the entire wing, including the L5 vein and
posterior crossvein, as well as the wing margin. The expres-
sion patterns of SNR1 and BRM are nearly identical in the
larval and pupal wing disc (our unpublished observations);
thus, SNR1 appears to be important for Brm complex ac-
tivities in restricted regions of the developing wing.
An unexpected finding was an important role for
SNR1 in sustained adult viability. Similar to effects
caused by expression of SNR1-2, flies rescued with a
heat-shock cDNA had a dramatically reduced viability
following eclosion (3 days). The reduced longevity is
unlikely due to nonspecific effects, such as accumulation
of overexpressed proteins, as our temperature-sensitive
snr1 mutant also exhibited shortened lifespans (7
days), and this effect was rescued by additional copies of
the wild-type gene (Marenda et al., 2003). Interestingly,
ash1, another member of the trx-G that genetically inter-
acts with both brm and trx, is also required for adult
viability (Landis et al., 2001). ASH1 is a component of a
large (2 MDa) complex distinct from the Brm complex
(Papoulas et al., 1998), but whose composition is un-
known. As ash1 is important for trx function (Rozovskaia
et al., 1999) and SNR1 physically and genetically inter-
acts with TRX (Marenda et al., 2003), it may be possible
that ASH1 can also form transient complexes with SNR1
in vivo. Thus, shortened adult viability may reflect re-
duced gene transcription due to disruption of Brm com-
plex activity or another complex, such as Ash1.
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SNR1 is a component of a subset of brm complexes
The SNR1/INI1 subunit copurifies with the fly and mam-
malian SWI/SNF complexes (Papoulas et al., 1998; Wang et
al., 1996), and the presence of INI1/hSNF5 helps to recon-
stitute full in vitro chromatin remodeling activity (Phelan et
al., 1999), suggesting that SNR1/INI1 is a core component.
BLAST database searches and reduced stringency hybrid-
ization confirmed that snr1 is the only SNF5-related gene in
flies (our unpublished results, and Papoulas et al., 1998).
Unlike loss-of-function mutations in brm, mor, and osa that
encode other subunits of the Brm complex, snr1 null alleles
are not significantly dosage-limiting in some sensitized ge-
netic assays. For example, snr1 null alleles do not suppress
a Pc mutant phenotype in the male prothoracic leg, an assay
that is often used to define members of the trx-G of activa-
tors (Kennison, 1995).
Consistent with our genetic studies of snr1, most Brm
complex components are also not encoded by previously
identified trx-G genes (Papoulas et al., 1998). Some of the
individual subunits may exist in excess of that required for
the formation or function of the complex, they may be
required for specific functions of the Brm complex, or they
may be components of other complexes, making null phe-
notypes difficult to interpret. Further, depending on the
specific target gene or tissue, a subunit may have different
regulatory functions on complex activities (activation or
repression); thus, removal of the subunit may have unantic-
ipated effects. SNR1 and BRM efficiently coprecipitate;
however, SNR1 is not detectably expressed in all tissues
where BRM is found at high levels (Elfring et al., 1998).
Unlike BRM, SNR1 is not found at elevated levels in the
notum portion of the third instar larval wing disc that gives
rise to dorsal thorax, and snr1 mutant clones revealed only
minor thoracic bristle defects that may represent loss of snr1
function in a restricted set of developing PNS cells. Simi-
larly, our snr1 conditional mutant did not display any sig-
nificant thoracic defects at any temperature (Marenda et al.,
2003). While we cannot rule out that earlier expression of
snr1 RNA or protein allows for the completion of normal
thoracic development after clone induction, ubiquitous ex-
pression of SNR1-2 also did not elicit thoracic phenotypes.
Strikingly, SNR1 was not present at detectable levels in
the leg discs, there were no SNR1-2 phenotypes in the legs,
nor has there been any evidence for a genetic role of snr1 in
the development of the legs (Dingwall et al., 1995; Marenda
et al., 2003), despite convincing requirements for other Brm
complex genes (Brizuela and Kennison, 1997; Collins et al.,
1999; Elfring et al., 1998; Kennison and Tamkun, 1988;
Tamkun et al., 1992). In addition to an absence of detectable
snr1 clone or dominant-negative expression phenotypes in
legs, genetic interaction tests using a snr1 null allele have
failed to reveal any function for snr1 in suppressing the
ectopic sex comb phenotype associated with mutations in
several Pc-G genes, including Pc (Pc1, Pc3, Pc4), Pcl11 and
E(z)60 (our unpublished observations). Furthermore, an un-
usual allele of the Pc-G gene E(z) that mimics trithorax
mutant phenotypes [E(z)Trm], including similar genetic in-
teractions, showed enhanced mutant phenotypes in the ab-
domen and legs in combination with alleles of brm, mor,
and osa; however, only the abdomen phenotype was en-
hanced by snr1 (Bajusz et al., 2001). Thus, SNR1 is not
required for Brm complex functions in leg development
and, perhaps similar to what has been proposed for OSA
(Collins et al., 1999), it appears to be an optional component
in a subset of Brm complexes.
Our finding that SNR1-2 expression phenotypes were
sensitive to snr1 dosage and that the truncated protein was
found predominantly in the cytoplasm raised the possibility
that SNR1-2 interfered with normal SNR1 function by an-
tagonizing specific interactions between the Brm complex
and cellular proteins. It appears unlikely that SNR1-2 phe-
notypes result from mislocalization of the Brm complex, as
we did not observe any cytoplasmic redistribution of BRM
following induction of SNR1-2 (our unpublished results).
Expression of large SNR1 deletions had no phenotype,
suggesting that expression of the N-terminal residues alone
was not deleterious, a view supported by our analyses of
snr1 mutant alleles that had similar truncations. The Repeat
regions in SNR1 and INI1 have been shown to mediate
specific protein contacts, acting independently or in concert
to promote the recruitment of the metazoan SWI/SNF com-
plexes to target loci (Cheng et al., 1999; Morozov et al.,
1998; Rozenblatt Rosen et al., 1998; Takayama et al., 2000).
For example, HIV integrase, the Epstein–Barr viral protein
EBNA2, c-MYC, and the human papillomavirus (HPV) E1
protein required for replication of the viral genome all
interact with INI1 through the repeat regions (Cheng et al.,
1999; Kalpana et al., 1994; Lee et al., 1999; Morozov et al.,
1998; Wu et al., 1996).
Interactions have been identified between SNR1/INI1
and the SET domains of the Drosophila trithorax (TRX) and
human trithorax (HRX) proteins (Rozenblatt Rosen et al.,
1998) that function as transcriptional regulators of the ho-
meotic genes. TRX physically interacts with SNR1 through
conserved residues within the Repeat 2 region, and their
interaction is important for proper development (Marenda et
al., 2003; Dingwall et al., 1995). As SNR1-2 can assemble
into Brm complexes and TRX did not associate with
SNR1-2 in vivo (data not shown), the observed phenotypes
might reflect diminished functions of TRX or other factors.
The activities of other cellular proteins are also likely to
require SNR1, including transcription factors such as Bicoid
(our unpublished data) and the cell cycle regulators Cyclin
E/CDK2 (Brumby et al., 2002), and these may be candidates
for functional disruption by SNR1-2. One possibility for a
protein shown to associate directly with Repeat 1 is c-MYC,
whose transactivation activity depends on interaction with
INI1 (Cheng et al., 1999; Takayama et al., 2000). Although
a functional homolog of c-MYC exists in flies (Gallant et
al., 1996; Johnston et al., 1999), it is unknown whether a
similar relationship exists between the Drosophila counter-
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parts or whether Drosophila c-MYC activity is affected by
expression of SNR1-2. Another possibility is that SNR1-2
protein in the cytoplasm associates with unknown proteins
and blocks their activity or transport into the nucleus, re-
flecting novel functions of the SNR1-2 protein. Further tests
are necessary to resolve among these and other possibilities.
Mounting evidence suggests that Brm complex subunits
have specific roles in defining the range of targets and
developmental functions of the complex. Mutations in mor
result in midgut abnormalities and reduced eye size (Brizu-
ela and Kennison, 1997). Ectopic expression of OSA affects
wing vein patterning and disrupts eye development, and
mutations in brm, mor, and snr1 can modulate those phe-
notypes (Collins et al., 1999). Genetically, osa functions in
concert with brm in wing tissues, but with opposite effect in
eyes, and osa has been shown to have genetic functions
distinct from both brm and mor in oogenesis (Vazquez et
al., 1999). Similarly, some snr1 mutant phenotypes overlap
with those of brm, and brm can suppress many of the snr1
conditional mutant phenotypes (Marenda et al., 2003).
Our data demonstrate a striking correspondence between
localization of SNR1/BRM and RNA PolII, suggesting a
critical role for the Brm complex in mediating global as-
pects of gene transcription regulation. Importantly, the Brm
complex accumulates at sites that are not being actively
transcribed, and it is not always associated with active PolII
transcription. While the Brm complex likely assists PolII
activity at many gene loci, it is not a core constituent of
RNA PolII holoenzyme, as has been suggested (Wilson et
al., 1996); thus, the Brm complex may have other roles in
regulating gene expression. Consistent with reports that the
yeast SWI/SNF complex can function in both gene activa-
tion and repression (Sudarsanam et al., 2000), the ectopic
wing veins observed in flies overexpressing SNR1-2 are
reminiscent of effects caused by derepression of specific
wing vein regulators (Bier, 2000). Further, loss of INI1/
hSNF5 results in derepression of cyclinD1 expression in
rhabdosarcoma tumor cell lines, possibly due to diminished
recruitment of a deacetylase activity by INI1 to the cyclin
D1 promoter (Zhang et al., 2002).
Position effect variegation (PEV) is the mosaic expres-
sion of a gene that has been moved to another position on
the chromosome and is a model system used extensively to
examine the effects of higher order chromosomal structure
on gene expression (Grigliatti, 1991; Reuter and Spierer,
1992; Weiler and Wakimoto, 1995). Although many genes
can influence the variegating phenotypes associated with
classical PEV, we found that snr1 exerts an effect as strong
as known suppressors of PEV [Su(var)205], and it geneti-
cally interacts with (suppresses) a known enhancer of PEV
[E(var)3-4]. Mutations in snr1 suppress the variegating eye
pigmentation phenotype associated with In(1)wm4h, while
mutations in brm, mor, and osa exhibit a slight enhancing
effect. Among the explanations for this difference, likely
possibilities are that SNR1 may be responsible to target
repressor functions of the Brm complex to specific gene loci
or that it functions to directly restrict or limit complex
activities.
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